Tradestie Institutional Equity Comparison Engine
CAMP vs CCCC โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CCCC Overall Edge
CCCC Captures Institutional Edge (2โ1 Pillars ยท 6โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to C4 Therapeutics, Inc. (CCCC) driven by superior Growth & Margin, Momentum & Technical while CAMP counters with relative strength in Options & Structure. Fundamentally, CAMP trades at N/M Forward P/E with -991.8% operating margin (+138.9% YoY revenue) versus CCCC at N/M Forward P/E and -315.9% operating margin (-24.6% YoY). In options structure, CAMP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CCCC sits in BREAKDOWN (3rd %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
CAMP N/M vs CCCC N/M Fwd P/E
Growth & Margin Winner
CCCC
Op Margin -991.8% vs -315.9% ยท YoY +138.9% vs -24.6%
Momentum & Technical Winner
CCCC
1Y -3.7% vs +3.4% ยท 52W Pos 22% vs 25%
Options & Structure Winner
CAMP
UNCLASSIFIED (N/A IV) vs BREAKDOWN (3rd %ile IV)
CAMP
NASDAQ
CAMP4 Therapeutics Corporation Common Stock
Pharmaceutical Preparations
$3.95
+2.33% 1D
Market Cap
$238.5M
1M Return
+25.8%
1Y Return
-3.66%
Forward P/E
N/M
Unified AI Score
43.9 / 100
HOLD
Tech 34.0
Fund 40.0
Flow 50.0
Mom 40.0
CCCC
NASDAQ
C4 Therapeutics, Inc.
Biological Products, (No Disgnostic Substances)
$2.56
-3.58% 1D
Market Cap
$362.4M
1M Return
-11.59%
1Y Return
+3.44%
Forward P/E
N/M
Unified AI Score
47.7 / 100
HOLD
Tech 33.0
Fund 51.0
Flow 64.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
CAMP -3.66%
CCCC +3.44%
Spread: +7.1 pp (CCCC Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | CAMP Revenue | CCCC Revenue | CAMP Op. Margin | CCCC Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2021 | N/A | $50M | N/A | -179.4% | CCCC |
| FY2022 | N/A | $30M | N/A | -416.6% | CCCC |
| FY2023 | $0M | $20M | -14822.6% | -669.8% | CCCC |
| FY2024 | $0M | $40M | -8142.3% | -336.1% | CCCC |
| FY2025 | $0M | $40M | -1502.4% | -320.5% | CCCC |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CAMP | CCCC | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $238.5M | $362.4M | Larger Scale | CCCC |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +138.9% | -24.6% | Higher Growth | CAMP |
| Operating Margin (TTM) Profitability | -991.8% | -315.9% | Higher Margin | CCCC |
| Net Profit Margin Profitability | 0.0% | -282.2% | Higher Margin | CAMP |
| Return on Equity (ROE) Capital Efficiency | -146.1% | -47.6% | Higher ROE | CCCC |
| 52-Week Range Position Momentum | 22% ($3โ$8) | 25% ($2โ$5) | Stronger Trend | CCCC |
| Beta / 30D Volatility Risk Regime | 1.34ฮฒ ยท 94% Vol | 1.46ฮฒ ยท 67% Vol | Lower Realized Risk | CCCC |
| Unified Institutional Score Composite Signal | 43.9 / 100 (HOLD) | 47.7 / 100 (HOLD) | Higher Composite | CCCC |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full CAMP vs CCCC Buy Guide
CAMP
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
CCCC
BREAKDOWN
118d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
3rd %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither CAMP nor CCCC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.